Solid execution and cost disciplinePoised for next phase of Transformational Journey Third Quarter 2024 Financial Highlights: Net Revenues of $1,333 million for the third quarter of 2024 were down 3% ...
NMDC's shares declined over 4 percent following the company's Q2FY25 results, which led JP Morgan to reaffirm its ...
Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...
In a state ranked 8th highest for pursuit-related deaths, traffic infractions or property crimes prompted the vast majority ...
Solid execution and cost disciplinePoised for next phase of Transformational Journey Third Quarter 2024 Financial Highlights: Net Revenues of $1,333 million for the third quarter of 2024 were down ...
The World and Lee found that 12 of the 45 (27%) eluding drivers who were killed in chases were ages 15 to 21. At least five ...
Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...
Since Idaho voters chose to open up Medicaid eligibility to more people in 2018, the expanded program has faced scrutiny over its cost versus cost-savings. Some of this debate may be renewed as new ...
Company has reported net profit after tax of Rs 111.29 Crore in latest quarter.The company’s top management includes Mr.Anand Roy, Mr.Deepak Ramineedi, Mr.Sumir Chadha, Mr.Utpal Sheth, Ms.Anisha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback